Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics episode artwork

EPISODE · May 28, 2025 · 45 MIN

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Michael Tolentino, MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics, to the podcast. Tune in to part one of this special two-part episode as we explore Michael's start in ophthalmology, groundbreaking treatments in intra-retinal therapy, and the importance of being a great communicator. Okay, let's start the podcast!  

Episode metadata supplied by the publisher feed · Published May 28, 2025

Embed this episode

Ready to play

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

0:00 45:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 45 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on May 28, 2025.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!